Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001415889-25-008872

CEO bought 145,000 shares at $0.35 ($50,663)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wettig Thane CEO 2025-03-24 Purchase +145,000 $0.35 $50,663 543,329 D: show line 1 in the form
Open-market purchases · 145,000 sh · avg $0.35 · $50,663
Loading xslF345X05/form4-03252025_090301.xml…